CN103393753B - Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN103393753B CN103393753B CN201310297384.3A CN201310297384A CN103393753B CN 103393753 B CN103393753 B CN 103393753B CN 201310297384 A CN201310297384 A CN 201310297384A CN 103393753 B CN103393753 B CN 103393753B
- Authority
- CN
- China
- Prior art keywords
- cardiovascular
- traditional chinese
- chinese medicinal
- medicinal composition
- cerebrovascular diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and aims to solve the technical problem that a traditional Chinese medicinal composition which is convenient to carry and take and can be used for effectively treating cardiovascular and cerebrovascular diseases is provided. The traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases is characterized by comprising the following raw materials by weight: 0.04-0.07g of bezoar, 0.5-1.5g of scorpion, 0.8-1.2g of pseudo-ginseng, 0.05-0.15g of antelope horn powder, 1-4g of ground beeltle, 0.5-1.5g of red-rooted salvia root, and 0.8-1.6g of suberect spatholobus stem. The traditional Chinese medicinal composition can be used for treating cardiovascular and cerebrovascular diseases, is small in preparation size, small in dosage and small in side effect, and is convenient to carry and take.
Description
Technical field
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of the present invention, belongs to Chinese herbal medicine preparation technology field.
Background technology
Cardiovascular and cerebrovascular disease refers to that heart and arteries sclerosis occur and the heart ischemia that causes or hemorrhage disease, comprises coronary heart diseases and angina pectoris, hypertension, arrhythmia, myocardial infarction, cerebral infarction wait indefinitely.Cardiovascular and cerebrovascular disease is known as the number one killer threatening human health always, and hypertension, hyperlipidemia, coronary heart disease, diabetes become " pestilence in epoch ".
Along with the raising of social life level and the quickening of work rhythm, cardiovascular and cerebrovascular disease has become the leading killer threatening middle-aged and elderly people healthy and long-lived.According to Ministry of Public Health statistics, the First episode age 1/3 of China's Patients with Cardiovascular/Cerebrovascular Diseases, its sickness rate, mortality rate, disability rate, relapse rate were all very high and complication is many below 60 years old: its sickness rate is up to 13.6%, and every day is with the speed increase of 20,000 people; Mortality rate, up to 45%, accounts for 50% of total death toll; Disability rate is high, patient with cerebral apoplexy disability rate up to 75%, patients with coronary artery disease becomes one able to do light manual labor only; Relapse rate is high, and in cardiovascular and cerebrovascular disease (heart infarction, cerebral infarction) 5 years, relapse rate is up to 42%; The disease of the respiratory system surprisingly caused by cardiovascular and cerebrovascular vessel, digestive system, urinary system etc. is more.Wherein hypertension, apoplexy and coronary heart disease are the representative diseases of cardiovascular and cerebrovascular disease.
Hypertension is with arteriotony rising for feature, with the systemic disease of the organ functional such as heart, blood vessel, brain and kidney or organic change.In China, the main directly complication of hypertension is cerebrovascular, especially cerebral hemorrhage.In 596 routine senile hypertensions follow-up observation in perspective 27 months research, the heart, cerebrovascular accumulate incidence are 92.79%, and cerebrovascular accumulate incidence is 76.91%.Research shows, blood pressure is higher, and the incidence rate of complication is also higher.More than 15 years old 5456 people in district in Shanghai show about the research of blood pressure and stroke onset relation, in 9 years of following up a case by regular visits to, patients with hypertension generation cerebrovascular accounts for 70% of whole crowd's cerebrovascular generation number, wherein Definite Hypertension suffers from 32 times that the relative risk of cerebrovascular is normotensive subjects, and borderline hypertension is also up to 9 times.Authority's survey data shows, patients with hypertension myocardial infarction prevalence and coronary heart disease incidence rate are 2.8 times and 3.5 times of normotensive subjects.
Hyperlipidemia, be a kind of common disease, not only in the middle of middle-aged and elderly people, sickness rate is high, and starts " favor " young white collar clan in recent years.Hyperlipemia, easily causes " blood is thick ", blood vessel wall deposits, and forms atherosclerosis.These deposits increase, increase, gradually artery-clogging, and make blood flow slack-off, time serious, blood flow is interrupted.If this situation occurs in heart, just cause coronary heart disease; If occur in kidney, renal arteriosclerosis, renal failure will be caused; Occur in lower limb, there will be limb necrosis, fester.In addition, hyperlipidemia can cause hypertension, brings out cholelithiasis, pancreatitis, increases the weight of hepatitis, causes the disease such as male sexual disorder, senile dementia.Therefore, hyperlipemia is not only blood fat any problem high, and its seriousness definitely can not be ignored.
Coronary heart disease is the most common type that atherosclerosis causes organ lesion, is also the commonly encountered diseases of serious harm people ' s health, and be the number one killer threatening human health, coronary heart disease death rate accounts for 10% ~ 20% of all deaths from heart disease numbers.The treatment of coronary heart disease is generally divided into Drug therapy, operative treatment and interventional therapy, its drug treatment mainly Western medicine, and the active drug for the treatment of by Chinese herbs is little; Operative treatment risk is larger, and interventional therapy expense is very expensive, and a lot of family burden does not rise.
Summary of the invention
The present invention overcomes the deficiencies in the prior art, technical problem to be solved be to provide a kind ofly to carry, the Chinese medicine composition of effective treatment cardiovascular and cerebrovascular disease of taking convenience.
For solving the problems of the technologies described above; the technical solution adopted in the present invention is: a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease; comprise the raw material of following weight: Calculus Bovis 0.04-0.07g; Scorpio 0.5-1.5g; Radix Notoginseng 0.8-1.2g, Cornu Saigae Tataricae powder 0.05-0.15g, Eupolyphaga Seu Steleophaga 1-4g; Radix Salviae Miltiorrhizae 0.5-1.5g, Caulis Spatholobi 0.8-1.6g.
As preferred a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.04-0.05g, Scorpio 0.8-1.2g; Radix Notoginseng 1-1.2g, Cornu Saigae Tataricae powder 0.08-0.12g, Eupolyphaga Seu Steleophaga 2-4g; Radix Salviae Miltiorrhizae 0.8-1.2g, Caulis Spatholobi 1-1.3g.
Described Chinese medicine composition is enriched pellet agent or is capsule.
Seven flavor medicine is formulated altogether in the present invention.Calculus Bovis GUIXIN liver, bitter in the mouth, property is sweet cool, and function cures mainly relieving convulsion, the function of gallbladder promoting of clearing away heart-fire, reduces phlegm; Radix Notoginseng returns stomach kidney, and mildly bitter flavor is warm in nature, and function cures mainly dissipating blood stasis, hemostasis, detumescence, analgesic therapy etc.; Radix Salviae Miltiorrhizae bitter in the mouth, warm in nature, function cures mainly blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, pain relieving, controls angina pectoris; Scorpio returns JUE YIN meridian, and salty in the mouth is trembled with fear, poisonous, and function cures mainly infantile convulsion, tic, only silt, dredging collateral, removing toxic substances, apoplexy etc.; Caulis Spatholobi returns Liver and kidney, bitter but sweet flavor temperature, function cure mainly enrich blood, invigorate blood circulation, the meridian dredging; Cornu Saigae Tataricae GUIXIN liver, salty in the mouth, cold in nature, function cures mainly suppressing the hyperactive liver to relieve the wind syndrome, liver heat removing and eyesight improving, loose blood removing toxic substances; Eupolyphaga Seu Steleophaga returns Liver Channel, salty in the mouth, cold in nature, slightly poisonous.
The beneficial effect that compared with prior art the present invention has is: the present invention take Calculus Bovis as monarch drug; be aided with Radix Notoginseng, Scorpio, Cornu Saigae Tataricae powder, Eupolyphaga Seu Steleophaga, Radix Salviae Miltiorrhizae, Caulis Spatholobi; preparation nature and flavor are proper; return through suitably; the monarch and his subjects are harmonious; to cardiovascular and cerebrovascular disease thrombolytic blood stasis dispelling, relieving convulsionly to dispel the wind, vessel softening has the curative effect of highly significant.A few herbal medicine of Chinese medicine composition of the present invention separately or the method with steeping in wine or the method with quench in vinegar or undertaken carrying element by the method for fire roasting, row nine changes the number of nine air dry, make pill or capsule, bolus volume is little, dosage is little, side effect is little, carry and take all very convenient.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described.
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of following examples, making becomes enriched pellet agent or capsule, and the efficacy of a drug drug effect of a described pill and capsule is equal to, and the instructions of taking of described pill or capsule is every day three times, each 2-3 grain, one after each meal.
Embodiment 1
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.05g, Scorpio 0.5g, Radix Notoginseng 1g, Cornu Saigae Tataricae powder 0.1g, Eupolyphaga Seu Steleophaga 2g, Radix Salviae Miltiorrhizae 1.2g, Caulis Spatholobi 1.4g.
Embodiment 2
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.05, Scorpio 0.8g, Radix Notoginseng 0.9g, Cornu Saigae Tataricae powder 0.12g, Eupolyphaga Seu Steleophaga 1g, Radix Salviae Miltiorrhizae 1.5g, Caulis Spatholobi 1.6g.
Embodiment 3
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.06g, Scorpio 1.2, Radix Notoginseng 0.8g, Cornu Saigae Tataricae powder 0.08g, Eupolyphaga Seu Steleophaga 2g, Radix Salviae Miltiorrhizae 0.8g, Caulis Spatholobi 0.8g.
Embodiment 4
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.04g, Scorpio 1g, Radix Notoginseng 1.2g, Cornu Saigae Tataricae powder 0.15g, Eupolyphaga Seu Steleophaga 3g, Radix Salviae Miltiorrhizae 1g, Caulis Spatholobi 1g.
Embodiment 5
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.07g, Scorpio 1.1g, Radix Notoginseng 1g, Cornu Saigae Tataricae powder 0.14g, Eupolyphaga Seu Steleophaga 4g, Radix Salviae Miltiorrhizae 1.3g, Caulis Spatholobi 1.2g.
Embodiment 6
Treat a Chinese medicine composition for cardiovascular and cerebrovascular disease, comprise the raw material of following weight: Calculus Bovis 0.06g, Scorpio 1.5g, Radix Notoginseng 1.1g, Cornu Saigae Tataricae powder 0.1g, Eupolyphaga Seu Steleophaga 3g, Radix Salviae Miltiorrhizae 0.9g, Caulis Spatholobi 1.3g.
Case 1
Mr. Huang, 67 years old, on March 22nd, 2010 was diagnosed as coronary atherosclerotic heart disease, labour/spontaneous angina, 3 grades of hypertension, hyperlipidemias.Treat routinely, often need to do PCI intervene operation, body is more weak, is reluctant to accept, and then takes Chinese medicine composition of the present invention, by each 3, take 6 courses for the treatment of (10 days courses for the treatment of) every day for 3 times to check afterwards, fatty liver alleviates, and left room increases, the a small amount of reflux of two Tricuspid valvies, Diastole Function reduces.
Case 2
Mr. Zhang, 54 years old, in December, 2012 was diagnosed as coronary atherosclerotic heart disease, exertional angina pectoris, 2 grades of hypertension; Receive Drug therapy of the present invention 6 courses for the treatment of (10 days courses for the treatment of), front 3 courses for the treatment of are by each 3, every day takes for 3 times, rear 3 courses for the treatment of, every day took for 3 times, further consultation in April in this year by each 2, check result is that left room is bigger, Diastole Function lowers, and contractile function is normal, mitral incompetence area 2.7cm
2, long 3.0cm.
The present invention can summarize with other the concrete form without prejudice to spirit of the present invention or principal character.Therefore, no matter from that, above-mentioned embodiment of the present invention all can only be thought explanation of the present invention and can not limit invention, claims indicate scope of the present invention, and scope of the present invention is not pointed out in above-mentioned explanation, therefore, any change in the implication suitable with claims of the present invention and scope, all should think to be included in the scope of claims.
Claims (3)
1. treat the Chinese medicine composition of cardiovascular and cerebrovascular disease for one kind; it is characterized in that effective ingredient is made up of the raw material of following weight: Calculus Bovis 0.04-0.07g; Scorpio 0.5-1.5g; Radix Notoginseng 0.8-1.2g; Cornu Saigae Tataricae powder 0.05-0.15g; Eupolyphaga Seu Steleophaga 1-4g, Radix Salviae Miltiorrhizae 0.5-1.5g, Caulis Spatholobi 0.8-1.6g.
2. a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1; it is characterized in that effective ingredient is made up of the raw material of following weight: Calculus Bovis 0.04-0.05g; Scorpio 0.8-1.2g; Radix Notoginseng 1-1.2g; Cornu Saigae Tataricae powder 0.08-0.12g; Eupolyphaga Seu Steleophaga 2-4g, Radix Salviae Miltiorrhizae 0.8-1.2g, Caulis Spatholobi 1-1.3g.
3. a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1 and 2, is characterized in that described Chinese medicine composition is enriched pellet agent or is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310297384.3A CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310297384.3A CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103393753A CN103393753A (en) | 2013-11-20 |
| CN103393753B true CN103393753B (en) | 2015-03-25 |
Family
ID=49557606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310297384.3A Active CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103393753B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104622930A (en) * | 2015-01-15 | 2015-05-20 | 孙喜翠 | Application of babao (Chinese character) pill in treatment of senile dementia and pharmaceutical composition of babao pill |
| CN105617355A (en) | 2016-01-29 | 2016-06-01 | 徐宝贞 | Medicine for treating cardiovascular and cerebrovascular diseases |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1580226A (en) * | 2003-08-01 | 2005-02-16 | 王青春 | Medicinal liquor and its preparing method |
| CN101019926A (en) * | 2007-02-13 | 2007-08-22 | 张宗保 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
-
2013
- 2013-07-16 CN CN201310297384.3A patent/CN103393753B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1580226A (en) * | 2003-08-01 | 2005-02-16 | 王青春 | Medicinal liquor and its preparing method |
| CN101019926A (en) * | 2007-02-13 | 2007-08-22 | 张宗保 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 治疗心脑血管疾病中成药微量和常量元素含量与疗效的模糊分类法则(英文);董顺福等;《中国临床康复》;20060305;第09卷(第15期);全文 * |
| 补肾活血冲剂治疗老年高血压病肾虚血瘀证90例疗效观察;田军彪等;《新中医》;20050405;第37卷(第04期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103393753A (en) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN103893727A (en) | Pain-relieving, blood-invigorating and tendon-relaxing plaster and preparation method thereof | |
| CN102727686A (en) | Traditional Chinese medicine composition for treating fatty liver | |
| CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
| CN102940865B (en) | Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof | |
| CN101032580B (en) | Medicine for treating rheumatic diseases | |
| CN103463297B (en) | A kind of Chinese medicine composition for the treatment of eczema scrotum and its production and use | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103393753B (en) | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
| CN101869671A (en) | Paste for waist, leg, shoulder and neck | |
| CN1132616C (en) | Traditional Chinese medicine for treating arthralgia-syndrome | |
| CN101897753B (en) | Traditional Chinese medicine for treating coronary disease and preparation method thereof | |
| CN110384785B (en) | A topical Chinese medicinal liquid for treating viral common cold, and its preparation method | |
| CN105079228A (en) | Traditional Chinese medicinal composition for assisting scraping and cupping, scraping oil and preparation method of scraping oil | |
| CN110833615A (en) | A Chinese medicinal composition for treating chronic rhinitis by umbilical therapy, and its preparation method | |
| CN104435798A (en) | Traditional Chinese medicine preparation for improving neurasthenia and preparation method thereof | |
| CN103432200B (en) | A kind of medicine for the treatment of Orthopeadic Surgery disease | |
| CN102357160B (en) | Chinese medicine for treating malaria | |
| CN102670839B (en) | External traditional Chinese medicine composition for treating hyperosteogeny | |
| CN102274408A (en) | Patch for treating hypertension | |
| CN104606406A (en) | External traditional Chinese medicine unguent for preventing allergic rhinitis and preparation method thereof | |
| CN104399012B (en) | A kind of Chinese medicine composition for primary liver cancer | |
| CN103202991A (en) | Drug for treatment of coronary heart disease and preparation method thereof | |
| CN114558097A (en) | Detoxifying, swelling-dispersing and stasis-dissipating patch for treating heat-toxin congestion type subacute thyroiditis | |
| CN102861186B (en) | Medicine for improving bioavailability of atorvastatin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |